Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(18%)

Phase Distribution

Ph phase_4
1
9%
Ph not_applicable
10
91%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(8)
Terminated(2)
Other(1)

Detailed Status

Completed8
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (9.1%)
N/A10 (90.9%)

Trials by Status

completed873%
unknown19%
terminated218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11